List view / Grid view

Eric Van Cutsem

 

news

ZALTRAP® (aflibercept) approved in the EU

First and only agent to statistically significantly improve survival in…

5 February 2013 | By Sanofi

First and only agent to statistically significantly improve survival in combination with FOLFIRI chemotherapy after an oxaliplatin regimen...